MHC tetramer detailed product information

Code No. TS-M007-2
T-Select HLA-A*24:02 Negative (HIV env) Tetramer-RYLRDQQLL-APC
Size 50 tests
Availability (in Japan) 0
(Contact us)
（In Japan at 00:05, Mar 9, 2026 in JST）
Class Class I
Animal species Human
Category virus
Conjugate APC
Immunogen (Antigen) HIV env gp160
Sequence RYLRDQQLL
MHC Allele A*24:02
Location (aa) 584-592
Storage temp. 4°C
Manufacturer MBL
Related products TS-M153-1 HLA-A*24:02 Control Tetramer-AYAAAAAAL-PE
TS-M153-2 HLA-A*24:02 Control Tetramer-AYAAAAAAL-APC
TS-M153-3 HLA-A*24:02 Control Tetramer-AYAAAAAAL-FITC
Product category Research area:Immunology
Tools:MHC tetramer
Citations
  1. Tsukahara T, et al., Prognostic impact and immunogenicity of a novel osteosarcoma antigen, papillomavirus binding factor, in patients with osteosarcoma. Cancer Sci. 99: 368?|375 (2008)(PMID:18271936)
  1. Kozako T, et al., Reduced frequency, diversity, and function of human T cell leukemia virus type 1-specific CD8+ T cell in adult T cell leukemia patients. J. Immunol. 177: 5718?|5726 (2006)(PMID:17015761)
  1. Akiyama Y, et al., Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells. J. Transl. Med. 3: 4?|13 (2005)(PMID:15676080)
  1. Akiyama Y, et al., Characterization of a MAGE-1-derived HLA-A24 epitope-specific CTL line from a Japanese metastatic melanoma patient. Anticancer Res. 29: 647?|655 (2009)(PMID:19331215)
  1. Akimoto M, et al., Anti-HTLV-1 tax antibody and tax-specific cytotoxic T lymphocyte are associated with a reduction in HTLV-1 proviral load in asymptomatic carriers. J. Med Virol. 79: 977?|86 (2007)(PMID:17516523)
  • The availability is based on the information in Japan at 00:05, Mar 9, 2026 in JST.
  • The special price is shown in red color.
  • Please note that products cannot be ordered from this website. To purchase the items listed in this website, please contact us or local distributers.
  • For storage temparature: RT: room temparature
  • Please note that products in this website might be changed or discontinued without notification in advance for quality improvement.
MBLCopyright (C)2015 Medical ＆ Biological Laboratories Co., Ltd. All Rights Reserve